PsylliumRx Dietary Fiber Study
NCT03629119 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2022-01-18
Summary
The purpose of this pilot study is to assess the feasibility of a 3-month dietary fiber intervention: 1) engaging adolescents in regularly consuming a dietary fiber preparation (psyllium powder) and obtaining their parents' support, 2) recruit into a clinical pilot trial with liquid meal challenge test to study the metabolic effects of the dietary fiber preparation. A study modification will be submitted to add additional study arms for feasibility (strength training, coaching).
Conditions
- Obesity
- Childhood Obesity
Interventions
- DIETARY_SUPPLEMENT
-
Dietary Fiber Supplement
Participants will be instructed to consume 1 tea spoon of psyllium per day for 3 months and otherwise maintain their habitual diet. Participants will be asked to keep a diary assessing bowel movement and intestinal symptoms such as bloating and flatulence beginning two weeks prior to the intervention.
Sponsors & Collaborators
-
Kaiser Permanente
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-07-31
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- United States
Study Locations
More Related Trials
-
Single Dose Study of PF-06815345 in Healthy Subjects
NCT02654899 ·Status: TERMINATED ·Phase: PHASE1
-
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
NCT02184429 ·Status: COMPLETED ·Phase: PHASE1
-
OPEN LABEL, 2-PERIOD STUDY, TO COMPARE BIO-AVAILABILITY OF 2 DIFFERENT FORMULATIONS OF PF-05221304 IN HEALTHY ADULTS
NCT03871439 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison Of The Pharmacokinetics Of PF-04191834 Following Single Dose Administration Of A Dispersion Formulation And A Suspension Formulation In Healthy Volunteers
NCT01265732 ·Status: WITHDRAWN ·Phase: PHASE1
-
Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects
NCT02871037 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Drug Exposures Of Two Formulations of PF-02341066
NCT00939731 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants
NCT04124653 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects
NCT02609139 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study Of PF-06291874 In Healthy Adult Subjects
NCT01499017 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Tolerability of PF-06818883 in Healthy Subjects
NCT03020784 ·Status: TERMINATED ·Phase: PHASE1
-
A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects
NCT01474941 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers
NCT02066909 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999
NCT01530529 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
NCT05536440 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
NCT02855177 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants
NCT05431153 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects
NCT01146327 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
NCT01794364 ·Status: COMPLETED ·Phase: PHASE1
-
A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants
NCT05434091 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
NCT02222441 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy Participants
NCT03180762 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.
NCT06532383 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State
NCT01706796 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults
NCT01753791 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.
NCT05178654 ·Status: WITHDRAWN ·Phase: PHASE1